225 related articles for article (PubMed ID: 28630039)
1. Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.
Wallin H; Apelqvist J; Andersson F; Ekström U; Abrahamson M
J Biol Chem; 2017 Sep; 292(35):14413-14424. PubMed ID: 28630039
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C properties crucial for uptake and inhibition of intracellular target enzymes.
Wallin H; Abrahamson M; Ekström U
J Biol Chem; 2013 Jun; 288(23):17019-17029. PubMed ID: 23629651
[TBL] [Abstract][Full Text] [Related]
3. Cystatin E/M suppresses legumain activity and invasion of human melanoma.
Briggs JJ; Haugen MH; Johansen HT; Riker AI; Abrahamson M; Fodstad Ø; Maelandsmo GM; Solberg R
BMC Cancer; 2010 Jan; 10():17. PubMed ID: 20074384
[TBL] [Abstract][Full Text] [Related]
4. Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M.
Smith R; Johansen HT; Nilsen H; Haugen MH; Pettersen SJ; Mælandsmo GM; Abrahamson M; Solberg R
Biochimie; 2012 Dec; 94(12):2590-9. PubMed ID: 22902879
[TBL] [Abstract][Full Text] [Related]
5. Silencing of cystatin M in metastatic oral cancer cell line MDA-686Ln by siRNA increases cysteine proteinases and legumain activities, cell proliferation and in vitro invasion.
Vigneswaran N; Wu J; Nagaraj N; James R; Zeeuwen P; Zacharias W
Life Sci; 2006 Jan; 78(8):898-907. PubMed ID: 16150465
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site.
Alvarez-Fernandez M; Barrett AJ; Gerhartz B; Dando PM; Ni J; Abrahamson M
J Biol Chem; 1999 Jul; 274(27):19195-203. PubMed ID: 10383426
[TBL] [Abstract][Full Text] [Related]
7. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
Cheng T; Hitomi K; van Vlijmen-Willems IM; de Jongh GJ; Yamamoto K; Nishi K; Watts C; Reinheckel T; Schalkwijk J; Zeeuwen PL
J Biol Chem; 2006 Jun; 281(23):15893-9. PubMed ID: 16565075
[TBL] [Abstract][Full Text] [Related]
8. Cystatins--Extra- and intracellular cysteine protease inhibitors: High-level secretion and uptake of cystatin C in human neuroblastoma cells.
Wallin H; Bjarnadottir M; Vogel LK; Wassélius J; Ekström U; Abrahamson M
Biochimie; 2010 Nov; 92(11):1625-34. PubMed ID: 20800088
[TBL] [Abstract][Full Text] [Related]
9. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
Pavlova A; Björk I
Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation is important for legumain localization and processing to active forms but not for cystatin E/M inhibitory functions.
Lunde NN; Haugen MH; Bodin Larsen KB; Damgaard I; Pettersen SJ; Kasem R; Rut W; Drag M; Poreba M; Johansen HT; Solberg R
Biochimie; 2017 Aug; 139():27-37. PubMed ID: 28528272
[TBL] [Abstract][Full Text] [Related]
11. Internalization of cystatin C in human cell lines.
Ekström U; Wallin H; Lorenzo J; Holmqvist B; Abrahamson M; Avilés FX
FEBS J; 2008 Sep; 275(18):4571-82. PubMed ID: 18699780
[TBL] [Abstract][Full Text] [Related]
12. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells.
Shridhar R; Zhang J; Song J; Booth BA; Kevil CG; Sotiropoulou G; Sloane BF; Keppler D
Oncogene; 2004 Mar; 23(12):2206-15. PubMed ID: 14676833
[TBL] [Abstract][Full Text] [Related]
13. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice.
Zeeuwen PL; van Vlijmen-Willems IM; Olthuis D; Johansen HT; Hitomi K; Hara-Nishimura I; Powers JC; James KE; op den Camp HJ; Lemmens R; Schalkwijk J
Hum Mol Genet; 2004 May; 13(10):1069-79. PubMed ID: 15044380
[TBL] [Abstract][Full Text] [Related]
14. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
Trinkaus M; Vranic A; Dolenc VV; Lah TT
Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
[TBL] [Abstract][Full Text] [Related]
15. Expression of cysteine proteinases and their inhibitor, cystatin beta, in cultured rat mesangial cells.
Makita Y; Ishidoh K; Kominami E; Funabiki K; Koide H; Tomino Y
J Diabetes Complications; 1998; 12(6):328-36. PubMed ID: 9877467
[TBL] [Abstract][Full Text] [Related]
16. Probing the functional role of the N-terminal region of cystatins by equilibrium and kinetic studies of the binding of Gly-11 variants of recombinant human cystatin C to target proteinases.
Björk I; Brieditis I; Abrahamson M
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):513-8. PubMed ID: 7887904
[TBL] [Abstract][Full Text] [Related]
17. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
Colella R; Casey SF
Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
[TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
Mason RW; Sol-Church K; Abrahamson M
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
[TBL] [Abstract][Full Text] [Related]
19. Externally added cystatin C reduces growth of A375 melanoma cells by increasing cell cycle time.
Wallin H; Hunaiti S; Abrahamson M
FEBS Open Bio; 2021 Jun; 11(6):1645-1658. PubMed ID: 33837649
[TBL] [Abstract][Full Text] [Related]
20. On Blastocystis secreted cysteine proteases: a legumain-activated cathepsin B increases paracellular permeability of intestinal Caco-2 cell monolayers.
Nourrisson C; Wawrzyniak I; Cian A; Livrelli V; Viscogliosi E; Delbac F; Poirier P
Parasitology; 2016 Nov; 143(13):1713-1722. PubMed ID: 27609526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
